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Synthesis of a spin-pair-labeled tripeptide  
Abbreviations: 
ACN   Acetonitrile 
Anal. Calc.  Analysis calculated 
Atm   Atmosphere 
DCM   Dichloromethane 
DIPEA   N, N'-Diisopropylethylamine 
DMF   N, N-Dimethylformamide 
DMSO   Dimethyl sulfoxide 
Equiv   Equivalent 
ESI   Electrospray ionization 
Fmoc   Fluorenylmethyloxycarbonyl chloride 
HOBt   Hydroxybenzotriazole 
HPLC   High-performance liquid chromatography 
hr   Hour 
HRMS   High resolution mass spectrometry 
IR   Infrared 
LC-MS   Liquid chromatography - mass spectrometry 
MeOH   Methanol 
min   Minute 
NMR   Nuclear magnetic resonance 
Pbf   2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl 
rpm   Revolutions per minute  
rt   Room temperature 
SPPS   Solid phase peptide synthesis 
SN1   Nucleophilic substitution 1 
TBTU   O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 
TFA   Trifluoroacetic acid 
TIS   Triisopropylsilane 
tR   Retention time 
 
I- Synthesis  
The synthesis of the spin-pair-labeled tripeptide 3-bromothiophene-2-carboxamido-Gly-Gly-Arg 
(henceforth ‘BT-GGR’) was performed by solid phase peptide synthesis (SPPS) using 2-chlorotrityl 
chloride resin and Fmoc protected amino acids (Scheme S1). The first step of this synthesis is a SN1 
substitution of Fmoc-Arg(Pbf)-OH on the resin. All remaining reactive 2-chlorotrityl groups were then 
capped with MeOH. The tripeptide was elaborated by successive couplings of Fmoc protected amino 
acids in the presence of HOBt and TBTU followed by deprotection of the N-terminus under basic 
conditions. Finally, 3-bromothiophene-2-carboxylic acid was conjugated at the N-terminus of the 
tripeptide. Cleavage from the resin, followed by deprotection of the arginine side chain, afforded the 
spin-pair-labeled tripeptide 6, which was purified by HPLC. 
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Scheme S1: Synthesis of spin-pair-labeled linear tripeptide BT-GGR 6. 
 
II- Synthetic steps 
N-Fmoc-Arg(Pbf)-O-resin (2): After swelling with dry DCM (80 mL) for 30 min, the 2-chlorotrityl 
chloride resin (0.83 mmol.g
-1
, 1 equiv, 2.49 mmol, 3 g) was treated with a solution of Fmoc-Arg(Pbf)-
OH (1) (2 equiv, 4.98 mmol, 3.23 g) in dry DCM/dry DMF (80 mL/10 mL) and DIPEA (8 equiv, 19.92 
mmol, 2.58 g, 3.52 mL) at rt for 1.5 hr agitated at 125 rpm. The reaction was performed in a 400 mL 
filtration tube with a polyethylene frit. The resin was washed with DMF (3 × 100 mL) and DCM (3 × 
100 mL) and dried for 12 hr in vacuo to give the N-Fmoc-Gly-O-resin (2). MeOH (30 mL) was added to 
cap the free sites, and the reaction mixture was shaken for 15 min at 125 rpm. The resin was washed 
with DMF (3 × 100 mL) and DCM (3 × 100 mL).  
N-Fmoc-Gly-Arg(Pbf)-O-resin (3): The Fmoc-protected resin (2) was suspended in a solution of 20% 
piperidine in DMF (30 mL) for 30 min and agitated at 125 rpm to give the N-deprotected resin. The 
resin was washed with DMF (3 × 100 mL), DCM (3 × 100 mL), and DMF (1 × 100 mL).  Fmoc-Gly-OH 
(1.5 equiv, 3.73 mmol, 1.11 g), HOBt (3 equiv, 7.47 mmol, 1.01 g), TBTU (3 equiv, 7.47 mmol, 2.40 g) 
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and DIPEA (6 equiv, 14.94 mmol, 1.94 g, 2.63 mL) were dissolved in dry DMF (30 mL). The solution 
was added to the N-deprotected resin. The reaction mixture was shaken at rt for 1 hr at 125 rpm to 
give Fmoc-Gly-Arg(Pbf)-O-resin (3) which was washed with DMF (3 × 100 mL), DCM (3 × 100 mL), 
DMF (1 × 100 mL).  
 
N-Fmoc-Gly-Gly-Arg(Pbf)-O-resin (4): The Fmoc-protected resin (3) was suspended in a solution of 
20% piperidine in DMF (30 mL) for 30 min and agitated at 125 rpm to give the N-deprotected resin. 
The resin was washed with DMF (3 × 100 mL), DCM (3 × 100 mL), and DMF (1 × 100 mL). Fmoc-Gly-
OH (1.5 equiv, 3.73 mmol, 1.11 g), HOBt (3 equiv, 7.47 mmol, 1.01 g), TBTU (3 equiv, 7.47 mmol, 2.40 
g), and DIPEA (6 equiv, 14.94 mmol, 1.94 g, 2.63 mL) were dissolved in dry DMF (30 mL). The solution 
was added to the N-deprotected resin. The reaction mixture was shaken at rt for 1 hr at 125 rpm to 
give Fmoc-Gly-Gly-Arg(Pbf)-O-resin (4) which was washed with DMF (3 × 100 mL), DCM (3 × 100 mL), 
and DMF (1 × 100 mL).  
 
3-bromothiophene-2-carboxamido-Gly-Gly-Arg(Pbf)-O-resin (5): The Fmoc-protected resin (4) was 
suspended in a solution of 20% piperidine in DMF (30 mL) for 30 min and agitated at 125 rpm to give 
the N-deprotected resin. The resin was washed with DMF (3 × 100 mL), DCM (3 × 100 mL), and DMF 
(1 × 100 mL). 3-bromothiophene-2-carboxylic acid (1.5 equiv, 3.73 mmol, 0.77 g), HOBt (3 equiv, 7.47 
mmol, 1.01 g), TBTU (3 equiv, 7.47 mmol, 2.40 g), and DIPEA (6 equiv, 14.94 mmol, 1.94 g, 2.63 mL) 
were dissolved in dry DMF (30 mL). The solution was added to the N-deprotected resin. The reaction 
mixture was shaken at rt for 1 hr at 125 rpm to give (5) which was washed with DMF (3 × 100 mL), 
DCM (3 × 100 mL), and DMF (1 × 100 mL).  
 
3-bromothiophene-2-carboxamido-Gly-Gly-Arg (6): After swelling with dry DCM (80 mL) for 30 min 
and washing with DMF (80 mL), (5) was treated with a solution of 5 % TFA in DCM (80 mL) for 30 min 
at rt to give the protected tripeptide. The reaction mixture was collected and the resin was washed 
with DCM (3 × 100 mL). The solution was concentrated and dried for 12 hr in vacuo. Finally, 
deprotection of the side chain group was carried out with 50 mL TFA:H2O:TIS (95:2.5:2.5) for 2 hr. 
TFA was then removed by evaporation and the final product (6) was obtained by purification with 
HPLC (Figure S1) (tR = 7.91 min). 
   (6) 
 
1
H NMR (400 MHz, DMSO-d6): δ 8.30 (td, J = 5.5, 2.6 Hz, 2H, NH), 8.08 (d, J = 7.8 Hz, 1H, CH(5)), 7.85 
(d, J = 5.2 Hz, 1H, NH), 7.61 (d, J = 7.0 Hz, 1H, CH(4)), 7.22 (d, J = 5.2 Hz, 4H, NH), 4.19 (td, J = 8.2, 5.0 
Hz, 1H, CH(9')), 3.94 (d, J = 5.5 Hz, 2H, CH2(6')), 3.87 – 3.70 (m, 2H, CH2(3')), 3.08 (q, J = 6.7 Hz, 2H, 
CH2(3'')), 1.74-1.59 (m, 2H, CH2(1'')), 1.49 (qt, J = 7.4 Hz, 2H, CH2(2'')). 
13
C-NMR (100 MHz, CDCl3): 
δ 173.4, 168.6, 160.2, 156.7, 132.9, 132.0, 130.7, 124.0, 118.9, 110.1, 51.6, 42.7, 41.8, 28.3, 
25.1. IR (neat): 3330, 3190, 3100, 2970, 2930, 1630, 1530, 1415, 1245, 1200, 1135, 1085, 
1050, 880, 760, 720, 685. HRMS-ESI: calculated for C15H22BrN6O5S+: 477.0478; found for 
C15H22BrN6O5S+: 477.0556.  
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Figure S1 a): HPLC spectrum: 2 to 60 % of solvent B (ACN:HCOOH 99.9:0.1) in solvent A (H2O:HCOOH 99.9:0.1) in 10 min. b) 
LC-MS spectrum after HPLC purification. c) 
1
H NMR of 6 in DMSO-d6 at 400 MHz and 25
o
 C. d) 
13
C NMR of 6 in CDCl3 at 100 
MHz and 25
o
 C.  
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Protein-Ligand Screening using Long-Lived Coherences (LLC) boosted 
by Dynamic Nuclear Polarization (DNP) 
In the singlet-triplet basis set, Long-Lived Coherences (LLC) (1-3) can be defined as a linear 
combination of |S0〉⟨T0| - |T0〉⟨S0| and |S0〉⟨T0| + |T0〉⟨S0|. These terms are equivalent to Ix – Sx and 
2IySz – 2IzSy in the product basis. An LLC experiment comprises similar steps as required for the 
observation of Long-Lived States (LLS): excitation, sustaining and detection. First, the Boltzmann 
equilibrium population Iz + Sz of an IS pair of chemically inequivalent spins is transformed into a 
density operator Ix – Sx (Figure S2), or alternatively into 2IySz – 2IzSy. Then, during a variable interval 
τm, the two spins are rendered magnetically equivalent by applying a resonant rf field with a carrier 
νrf positioned at the average of the chemical shifts of the two spins that are involved in the LLC. After 
interrupting the rf irradiation, the free induction signal is acquired as usual. The detectable single-
quantum coherences are best described in the product basis as a function of τm:  
 
 = 	 
 −	 cos2 +	2 −	2 sin2 exp "− #$%&&'(		       (S1) 
 
The observation of Ix – Sx as function of τm gives an oscillatory decay that can be Fourier transformed 
to obtain a so-called J-spectrum with very narrow line widths ΔνLLC = 1/(πTLLC). A LLC has a lifetime TLLC 
that is often much longer than the conventional transverse relaxation time T2 of the corresponding 
protons. Just like the lifetimes TLLS of Long-Lived States, the lifetimes TLLC can be dramatically reduced 
if the ligand that carries the LLC binds to a protein.  
 
 
Figure S2: Pulse sequences designed to excite, sustain and detect LLC. (a) in the manner of two-dimensional spectroscopy,  
with N1 steps τm = n1∆τm, n1 = 0, 1, 2, ..., (N1-1), and (b) using a one-dimensional ‘on-the-fly’ fast acquisition method. 
Typically, τ1 = 1/2ΔνIS to achieve an efficient conversion of Iy + Sy into Ix – Sx and τaq = 500 μs, ∆τm = 50 ms to have a 
bandwidth of the J-spectrum of 20 Hz, τaq = 500 μs, τLLC + 2τaq + τπ = ∆τm = 50 ms.  
 
This oscillatory decay can be sampled by incrementing τm in the manner of two-dimensional 
spectroscopy (Fig. S2a). To reduce the experimental time, it is possible to sample the exponential 
decay of the sinusoidal signal by choosing delays τm in the vicinity of the maxima that appear at 
multiples of 1/JIS (Fig.S 3). We have acquired signals for three τm delays that are close to each of these 
maxima. A local fit of these three signal amplitudes permits one to determine one of the maxima of 
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the sinusoidal signal (Fig.S 4). The value of TLLC is obtained by a mono-exponential fit of the envelope 
of consecutive maxima (Fig S5). 
 
By alternating intervals for signal observation and for sustaining the LLC, one can also observe N1 
points of an ‘on-the-fly’ LLC signal in a single shot (1) in the manner of one-dimensional spectroscopy 
(Fig. S2b).  The rf irradiation is briefly interrupted so that part of the oscillating LLC is temporarily 
transformed into observable single-quantum coherence in a window τaq, refocused by a pi pulse, 
before being transformed back into LLC by switching the rf irradiation on again. One of the 
advantages of this fast acquisition scheme is to make the LLC method fully compatible with 
dissolution DNP (4),  
 
Figure S3: Sampling the oscillating LLC decay. Sampling around the maxima of the sinusoidally modulated decay of the LLC 
signals (green dots) allows one to determine the time constant TLLC by fitting to an exponential curve (red).  
 
 
Figure S4: Local fit near three points. The signal amplitudes at three points (blue dots) taken near a maximum of the 
sinusoidally modulated decay of an LLC signal allows one to determine the amplitude of the maximum (arrow) by local 
fitting (red curve).  
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Figure S5: Experimental LLC decay. Fitting of 11 consecutive maxima of the sinusoidally modulated decay of an LLC signal 
allows one to determine TLLC. 
 
Since Long-Lived Coherences (LLC) belong to the class of zero-quantum coherences, their precession 
and decay are not sensitive to the inhomogeneity of the static magnetic field. If one excites an LLC 
via zero-quantum coherences, the efficiency of its excitation is not sensitive to the homogeneity of 
the static magnetic field (5). When all shim coil currents are set to zero (so that normal proton 
spectra show line widths of about 50 Hz), LLC spectra of free BT-GGR can be obtained with line 
widths as narrow as ΔνLLC
free
 = 0.20 Hz (TLLC
free
 = 1.5 s), i.e., a resolution enhancement of a factor of 50 
000 (5). As LLC spectra can be acquired in a single shot, the method can be combined with dissolution 
DNP (1, 4). 
 
Although the lifetimes of Long-Lived Coherences (LLC) associated with the two diastereotopic 
protons of the central Glycine in GGR turned out to be rather disappointing, the LLC associated with 
the two aromatic protons of bromothiophene of BT-GGR (TLLC
free 
= 1.5 s) is ideal for ligand screening. 
With a ligand/protein ratio [L]0/[P]0 = 40, a contrast CLLC of 82 % was obtained. Figure 5c in the main 
text shows LLC spectra of 0.5 mM BT-GGR in the presence of 25 μM trypsin, either without 
competitor, or with 50 μM of the intermediate competitor apigenin, or with 50 μM of the stronger 
competitor myricetin. All LLC spectra were recorded “on the fly” with the sequence of Figure S2b. In 
the absence of competitor, the protein concentration available for binding with the “spy ligand” BT-
GGR is [P]free = [P]0, so that one observes a fairly short TLLC
obs 
= 0.81 s and LLC spectra with fairly broad 
lines ΔνLLC
obs
 = 1/(πTLLC
obs
) = 0.39 Hz. In the presence of a binder that has a stronger affinity for the 
protein than the “spy ligand” BT-GGR, [P]free decreases, TLLC
obs
 becomes longer, the peak narrower, 
and its intensity higher (see Figure 5c and 5d of the main text). 
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